Paper

Paper

Changelog Terms Privacy Issues Docs Support Foundation About

Prognostic Impact of Sarcopenia Assessed Using Modified A... | ResearchHub

Paper

Paper

Supporters

Support the authors with ResearchCoin

Journal

Canadian Journal of Cardiology

Topics

Internal Medicine

Geriatrics And Gerontology

DOI

10.1016/j.cjca.2024.07.031

Changelog Terms Privacy Issues Docs Support Foundation About

Prognostic Impact of Sarcopenia Assessed Using Modified Asian Working Group for Sarcopenia 2019 Criteria in Heart Failure

0

Authors

Taisuke Nakade

Taisuke Nakade•Daichi Maeda•Tohru Minamino

Published

August 1, 2024

Abstract

Sarcopenia is a substantial therapeutic target, yet the validity of risk stratification values per the latest Asian Working Group for Sarcopenia in 2019 (AWGS 2019) remains unconfirmed in patients with heart failure. We hypothesized that using the 6-minute walk test (6MWT) to assess physical performance improves risk stratification.

Supporters

Support the authors with ResearchCoin

Journal

Canadian Journal of Cardiology

Topics

Internal Medicine

Geriatrics And Gerontology

DOI

10.1016/j.cjca.2024.07.031